中国骨与关节外科
中國骨與關節外科
중국골여관절외과
CHINESE BONE AND JOINT SURGERY
2014年
5期
416-421
,共6页
赵栋%梁炳生%胡宏亮%李永平
趙棟%樑炳生%鬍宏亮%李永平
조동%량병생%호굉량%리영평
股骨头坏死%激素%阿托伐他汀%氯吡格雷
股骨頭壞死%激素%阿託伐他汀%氯吡格雷
고골두배사%격소%아탁벌타정%록필격뢰
osteonecrosis,femoral head%hormone%atorvastatin%clopidogrel
目的:研究联合应用阿托伐他汀和氯吡格雷对SANFH兔动物模型的血脂及血浆黏度的影响,探讨联合用药对预防及治疗SANFH的可行性和机制。<br> 方法:将24只健康成年新西兰大白兔随机分为3组各8只:A组为模型组,采用Kabata造模法(第1周经耳缘静脉注射马血清10 ml/kg,间隔3周后注射第2次马血清,第5周时连续3 d腹腔内注射地塞米松磷酸钠10 mg/kg· d)制作SAN-FH模型;B组为治疗组,造模法同模型组,腹腔注射激素后每日给予抗凝药物氯吡格雷4 mg/kg和降脂药阿托伐他汀3 mg/kg灌胃;C组为对照组,马血清注射方法同模型组,而第5周时改为连续3 d腹腔内注射生理盐水4 ml/kg· d。各组分别于实验前、第5周注射激素或生理盐水后、第6周、第8周及第10周检测血清胆固醇、甘油三酯及血浆黏度,并行X线片检查及股骨头与肝脏病理切片观察病变情况。<br> 结果:模型组和治疗组的血清胆固醇、甘油三酯含量及血浆黏度均显著高于对照组,模型组的血清胆固醇、甘油三酯含量及血浆黏度显著高于治疗组,两两比较均有统计学差异(P<0.05),提示药物早期干预有效。通过X线片检查及病理切片可见治疗组股骨头坏死发生率明显低于模型组,而对照组未出现股骨头坏死。<br> 结论:联合应用阿托伐他汀和氯吡格雷可以明显抵消激素对血脂和血浆黏度的影响,可能对预防SANFH具有一定作用。
目的:研究聯閤應用阿託伐他汀和氯吡格雷對SANFH兔動物模型的血脂及血漿黏度的影響,探討聯閤用藥對預防及治療SANFH的可行性和機製。<br> 方法:將24隻健康成年新西蘭大白兔隨機分為3組各8隻:A組為模型組,採用Kabata造模法(第1週經耳緣靜脈註射馬血清10 ml/kg,間隔3週後註射第2次馬血清,第5週時連續3 d腹腔內註射地塞米鬆燐痠鈉10 mg/kg· d)製作SAN-FH模型;B組為治療組,造模法同模型組,腹腔註射激素後每日給予抗凝藥物氯吡格雷4 mg/kg和降脂藥阿託伐他汀3 mg/kg灌胃;C組為對照組,馬血清註射方法同模型組,而第5週時改為連續3 d腹腔內註射生理鹽水4 ml/kg· d。各組分彆于實驗前、第5週註射激素或生理鹽水後、第6週、第8週及第10週檢測血清膽固醇、甘油三酯及血漿黏度,併行X線片檢查及股骨頭與肝髒病理切片觀察病變情況。<br> 結果:模型組和治療組的血清膽固醇、甘油三酯含量及血漿黏度均顯著高于對照組,模型組的血清膽固醇、甘油三酯含量及血漿黏度顯著高于治療組,兩兩比較均有統計學差異(P<0.05),提示藥物早期榦預有效。通過X線片檢查及病理切片可見治療組股骨頭壞死髮生率明顯低于模型組,而對照組未齣現股骨頭壞死。<br> 結論:聯閤應用阿託伐他汀和氯吡格雷可以明顯牴消激素對血脂和血漿黏度的影響,可能對預防SANFH具有一定作用。
목적:연구연합응용아탁벌타정화록필격뢰대SANFH토동물모형적혈지급혈장점도적영향,탐토연합용약대예방급치료SANFH적가행성화궤제。<br> 방법:장24지건강성년신서란대백토수궤분위3조각8지:A조위모형조,채용Kabata조모법(제1주경이연정맥주사마혈청10 ml/kg,간격3주후주사제2차마혈청,제5주시련속3 d복강내주사지새미송린산납10 mg/kg· d)제작SAN-FH모형;B조위치료조,조모법동모형조,복강주사격소후매일급여항응약물록필격뢰4 mg/kg화강지약아탁벌타정3 mg/kg관위;C조위대조조,마혈청주사방법동모형조,이제5주시개위련속3 d복강내주사생리염수4 ml/kg· d。각조분별우실험전、제5주주사격소혹생리염수후、제6주、제8주급제10주검측혈청담고순、감유삼지급혈장점도,병행X선편검사급고골두여간장병리절편관찰병변정황。<br> 결과:모형조화치료조적혈청담고순、감유삼지함량급혈장점도균현저고우대조조,모형조적혈청담고순、감유삼지함량급혈장점도현저고우치료조,량량비교균유통계학차이(P<0.05),제시약물조기간예유효。통과X선편검사급병리절편가견치료조고골두배사발생솔명현저우모형조,이대조조미출현고골두배사。<br> 결론:연합응용아탁벌타정화록필격뢰가이명현저소격소대혈지화혈장점도적영향,가능대예방SANFH구유일정작용。
Background:Steroid-induced avascular necrosis of the femoral head (SANFH) is usually treated by surgical methods. How-ever, there are few reports on expectant treatment for the disease. <br> Objective:To study the effects of combined application of atorvastatin and clopidogrel on blood fat and viscosity of SANFH rabbits, and to investigate the feasibility and mechanism of medicine intervention for precaution and treatment of SANFH. <br> Methods: Twenty-four healthy adult New Zealand white rabbits were randomly divided into three groups (n=8): model group, treatment group, and control group. SANFH rabbit models were established by the Kabata method in model group and treatment group (10 ml/kg equine serum was injected into ear-vein on week 1 and 4 of the study, then 10 mg/kg· d dexa-methasone sodium phosphate was injected intraperitoneally for 3 days on week 5). After that, in the treatment group, rabbits was intragastrically administrated with 4mg/kg of clopidogrel and 4mg/kg· d atorvastatin daily. In the control group, 10 ml/kg equine serum was injected into ear-vein on week 1 and 4 of the study, and 4 mg/kg· d normal saline was injected intraperitone-al ly for 3 days on week 5. Serum cholesterol, triglyeride and plasma viscosity were tested before experiment and ond week 5, 6, 8, and 10 of the experiment. The changes of femoral head and liver were observed through X-ray and pathological section. <br> Results: Compared with those in the control group, serum cholesterol, triglyeride and plasma viscosity of model group and treatment group were significantly increased (P<0.05). The above-mentioned parameters in the model group were significant-ly higher than those in the treatment group (P<0.05). The results of X-ray and pathological section showed that the incidence of SANFH of treatment group was obviously lower than that of model group, and no ONFH was found in the control group. <br> Conclusions:Atorvastatin and clopidogrel application can obviously decrease blood viscosity and fat metabolic disorder in SANFH rabbits, which maybe contribute to prevent SANFH.